Literature DB >> 28362500

Antibacterial Compounds from Marine Bacteria, 2010-2015.

Claudia Schinke1, Thamires Martins1, Sonia C N Queiroz2, Itamar S Melo2, Felix G R Reyes1.   

Abstract

This review summarizes the reports on antibacterial compounds that have been obtained from marine-derived bacteria during the period 2010-2015. Over 50 active compounds were isolated during this period, most of which (69%) were obtained from Actinobacteria. Several compounds were already known, such as etamycin A (11) and nosiheptide (65), and new experiments with them showed some previously undetected antibacterial activities, highlighting the fact that known natural products may be an important source of new antibacterial leads. New broad-spectrum antibacterial compounds were reported with activity against antibiotic resistant Gram-positive and Gram-negative bacteria. Anthracimycin (33), kocurin (66), gageotetrins A-C (72-74), and gageomacrolactins 1-3 (86-88) are examples of compounds that display promising properties and could be leads to new antibiotics. A number of microbes produced mixtures of metabolites sharing similar chemical scaffolds, and structure-activity relationships are discussed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28362500     DOI: 10.1021/acs.jnatprod.6b00235

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  19 in total

Review 1.  Streptomycetes: Surrogate hosts for the genetic manipulation of biosynthetic gene clusters and production of natural products.

Authors:  Keshav K Nepal; Guojun Wang
Journal:  Biotechnol Adv       Date:  2018-10-09       Impact factor: 14.227

Review 2.  Mining for novel antibiotics.

Authors:  Justin R Randall; Bryan W Davies
Journal:  Curr Opin Microbiol       Date:  2021-07-02       Impact factor: 7.584

3.  Anti-BACE1 and Antimicrobial Activities of Steroidal Compounds Isolated from Marine Urechis unicinctus.

Authors:  Yong-Zhe Zhu; Jing-Wen Liu; Xue Wang; In-Hong Jeong; Young-Joon Ahn; Chuan-Jie Zhang
Journal:  Mar Drugs       Date:  2018-03-14       Impact factor: 5.118

4.  New Ansamycins from the Deep-Sea-Derived Bacterium Ochrobactrum sp. OUCMDZ-2164.

Authors:  Yaqin Fan; Cong Wang; Liping Wang; Arthit Chairoungdua; Pawinee Piyachaturawat; Peng Fu; Weiming Zhu
Journal:  Mar Drugs       Date:  2018-08-15       Impact factor: 5.118

Review 5.  Bioactivities of Halometabolites from Marine Actinobacteria.

Authors:  Noer Kasanah; Triyanto Triyanto
Journal:  Biomolecules       Date:  2019-06-11

6.  Phocoenamicins B and C, New Antibacterial Spirotetronates Isolated from a Marine Micromonospora sp.

Authors:  Mercedes Pérez-Bonilla; Daniel Oves-Costales; Mercedes de la Cruz; Maria Kokkini; Jesús Martín; Francisca Vicente; Olga Genilloud; Fernando Reyes
Journal:  Mar Drugs       Date:  2018-03-16       Impact factor: 5.118

7.  Identification, Characteristics and Mechanism of 1-Deoxy-N-acetylglucosamine from Deep-Sea Virgibacillus dokdonensis MCCC 1A00493.

Authors:  Dian Huang; Zong-Ze Shao; Yi Yu; Min-Min Cai; Long-Yu Zheng; Guang-Yu Li; Zi-Niu Yu; Xian-Feng Yi; Ji-Bin Zhang; Fu-Hua Hao
Journal:  Mar Drugs       Date:  2018-02-07       Impact factor: 5.118

8.  Bacillamidins A⁻G from a Marine-Derived Bacillus pumilus.

Authors:  Si-Yu Zhou; Yi-Jie Hu; Fan-Cheng Meng; Shen-Yue Qu; Rui Wang; Raymond J Andersen; Zhi-Hua Liao; Min Chen
Journal:  Mar Drugs       Date:  2018-09-11       Impact factor: 5.118

9.  Xanthones and Quinolones Derivatives Produced by the Deep-Sea-Derived Fungus Penicillium sp. SCSIO Ind16F01.

Authors:  Feng-An Liu; Xiuping Lin; Xuefeng Zhou; Minghao Chen; Xiuling Huang; Bin Yang; Huaming Tao
Journal:  Molecules       Date:  2017-12-07       Impact factor: 4.411

10.  Streptomyces nigra sp. nov. Is a Novel Actinobacterium Isolated From Mangrove Soil and Exerts a Potent Antitumor Activity in Vitro.

Authors:  Can Chen; Yanghui Ye; Ruijun Wang; Yinglao Zhang; Chen Wu; Sanjit C Debnath; Zhongjun Ma; Jidong Wang; Min Wu
Journal:  Front Microbiol       Date:  2018-07-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.